Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Cable

Orthopaedic Surgery New Orleans, LA Medical Doctor

NPI 1104054832 CMS profile 480239

1542 Tulane Ave, 6Th Floor, Rm 623, New Orleans, LA 70112

Open in the dashboard

General payments

$78,591

315 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Cable of New Orleans, LA is reported in the CMS Open Payments database as having received $78,591 across 315 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,486 58
2024 General $45,924 94
2023 General $10,238 42
2022 General $9,997 44
2021 General $3,568 39
2020 General $2,410 14
2019 General $967 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Cable
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Matthew Cable were reported at $5,486. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Matthew Cable Orthopaedic Surgery median Middle half National median
2019 $967 $644 $140–$2,844 $163
2020 $2,410 $312 $75–$1,860 $114
2021 $3,568 $520 $117–$2,495 $132
2022 $9,997 $598 $128–$2,731 $149
2023 $10,238 $461 $128–$2,264 $160
2024 $45,924 $497 $134–$2,475 $164
2025 $5,486 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $53,039 73 payments
  2. Musculoskeletal Transplant Foundation Inc. $5,600 5 payments
  3. Stryker Corporation $4,642 147 payments
  4. Carbofix Orthopedics Inc $3,697 21 payments
  5. Deciphera Pharmaceuticals Inc. $2,569 5 payments
  6. Daiichi Sankyo Inc. $2,118 1 payment
  7. Alon Medical Technology $1,200 1 payment
  8. Merete Technologies, Inc $1,000 1 payment
  9. Onkos Surgical, Inc. $823 14 payments
  10. Next Science LLC $385 4 payments
  11. Other $3,519 43 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $43,585 11 payments
  2. Food and Beverage $12,604 264 payments
  3. Travel and Lodging $9,777 29 payments
  4. Honoraria $6,755 5 payments
  5. Consulting Fee $3,170 4 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $1,500 1 payment
  7. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. OSTEOCOOL RF ABLATION SYSTEM $36,394 49 payments
  2. INTELLIS ADAPTIVESTIM $14,984 20 payments
  3. VIMSELTINIB $2,569 5 payments
  4. Turalio $2,118 1 payment
  5. MAKO Knees, Hips $946 16 payments
  6. ELEOS LIMB SALVAGE SYSTEM $698 12 payments
  7. TRIATHLON $519 13 payments
  8. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $390 5 payments
  9. INSPACE $388 5 payments
  10. MAKO Knees, Hips $376 5 payments
  11. Other $7,015 179 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$30,843

Medicare's payments for the services billed

Medicare patients

37

Average age 69

Services billed

96

21 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Diabetes 41%
Depression 38%
Chronic kidney disease 35%
Cancer 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VIJOICE
  • Novartis Pharmaceuticals Corporation $114
$114 — —
OGSIVEO
  • SpringWorks Therapeutics, Inc. $71
$71 — —
Zilretta
  • Pacira Pharmaceuticals Incorporated $7
$7 — —
Exparel
  • Pacira Pharmaceuticals Incorporated $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

315 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record